It was shown that combining anti-CTLA-4 and anti-PD-L1 antibodies (P1C4) with irradiation would enable exerting higher distant effects as well as providing greater local antitumor efficiency for osteosarcoma. Here, CTLA4 is linked to osteosarcoma.